JPM vs PB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Prosperity Bancshares presents a conflicting profile: it is fundamentally undervalued on an asset basis (P/B 0.85) and below its Graham Number ($100.73), yet it exhibits severe financial health deterioration with a Piotroski F-Score of 2/9. While revenue growth is strong at 19.9%, earnings are contracting (-15.1% YoY), likely reflecting the costs and integration of a recent acquisition. The significant gap between the Graham Number and the growth-based Intrinsic Value ($38.57) suggests the stock is a value trap if earnings do not recover. Bearish insider activity and a 0/100 technical trend further dampen the outlook despite bullish analyst targets.
Compare Another Pair
Related Comparisons
JPM vs PB: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Prosperity Bancshares, Inc. (PB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.